Market Tracker

07/01 5:41am ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

3.48
Delayed Data
As of Jun 30
 -0.03 / -0.85%
Today’s Change
2.72
Today|||52-Week Range
12.46
-21.80%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close3.51
Today’s open3.54
Day’s range3.45 - 3.65
Volume300,842
Average volume (3 months)187,440
Market cap$191.7M
Dividend yield--
Data as of 06/30/2016

Growth & Valuation

Earnings growth (last year)+25.56%
Earnings growth (this year)-10.88%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+66.34%
P/E ratio--
Price/Sales8.13
Price/Book0.35

Competitors

 Today’s
change
Today’s
% change
CYNACynapsus Therapeutic...+1.41+9.19%
FLKSFlex Pharma Inc-0.29-2.76%
VTLVital Therapies Inc-0.12-1.90%
FOMXFoamix Pharmaceutica...-0.05-0.78%
Data as of 06/30/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$24.9M
Annual profit (last year)-$61.1M
Net profit margin-245.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts